Mar 15, 2022
Data Demonstrates Clinically Meaningful and Statistically Significant Results, Improving Glycemic Control by Reducing A1c 0.4% Versus the Control Group Receiving Standard of Care SAN FRANCISCO --(BUSINESS WIRE)--Mar. 15, 2022-- Better Therapeutics, Inc. (“Better Therapeutics”, NASDAQ: BTTX), a
Jan 20, 2022
SAN FRANCISCO --(BUSINESS WIRE)--Jan. 20, 2022-- Better Therapeutics, Inc. (“Better Therapeutics”; NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing cognitive behavioral therapy to address root causes of cardiometabolic diseases, today announced that Kevin Appelbaum ,
Displaying 51 - 60 of 87